Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
Many patients require an fMRI as a prerequisite to therapy. Conditions for which this will/may be required include: chronic pain; stroke; concussion; and, traumatic brain injury (TBI). In addition to those disorders, it has been our experience at TheraMind that using an Advanced MRI to target therapy increases the success rate for achieving remission from depression using TMS therapy. Such targeting techniques are expected to enhance the efficacy of treatments for other mood disorders as well. Thus, patients presenting with mood disorders will be offered the opportunity to incorporate an fMRI into the diagnostic regimen.